Shuttle Pharmaceuticals Holdings (SHPH) Current Leases (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Current Leases came in at $79962.0 in Q1 2026, up 26.47% year-on-year from $63226.0 in Q1 2025, and up 3.59% quarter-over-quarter from $77194.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Current Leases (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Current Leases history runs 6 years deep, the most recent figure standing at $79962.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 26.47% year-over-year to $79962.0 in Q1 2026; TTM through Mar 2026 was $79962.0, a 26.47% increase from a year earlier, with the FY2025 full-year figure at $77194.0, up 26.74% from the prior year.
- Current Leases improved to $79962.0 in Q1 2026 per SHPH's latest filing, from $77194.0 in the prior quarter.
- Across five years, Current Leases topped out at $79962.0 in Q1 2026 and bottomed at $44633.0 in Q1 2023.
- The 5-year median for Current Leases is $62092.0 (2024), against an average of $63910.9.
- Across the five-year window, Current Leases declined 17.19% in 2023 and rose 27.02% in 2025, its largest moves.
- Year by year, Current Leases stood at $62823.0 in 2022, then decreased by 16.47% to $52479.0 in 2023, then rose by 16.06% to $60909.0 in 2024, then rose by 26.74% to $77194.0 in 2025, then advanced by 3.59% to $79962.0 in 2026.
- Per Business Quant, the three latest SHPH Current Leases figures stand at $79962.0 (Q1 2026), $77194.0 (Q4 2025), and $74497.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | 79,962.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,962.00 |
| Dec 31, 2025 | 77,194.00 |
| Sep 30, 2025 | 74,497.00 |
| Jun 30, 2025 | 71,869.00 |
| Mar 31, 2025 | 63,226.00 |
| Dec 31, 2024 | 60,909.00 |
| Sep 30, 2024 | 58,652.00 |
| Jun 30, 2024 | 62,092.00 |
| Mar 31, 2024 | 54,552.00 |
| Dec 31, 2023 | 52,479.00 |
| Sep 30, 2023 | 61,034.00 |
| Jun 30, 2023 | 61,034.00 |
| Mar 31, 2023 | 44,633.00 |
| Dec 31, 2022 | 62,823.00 |
| Sep 30, 2022 | 73,707.00 |
| Dec 31, 2021 | 66,934.00 |